“The nëo™ aEEG and EEG monitor by ANT Neuro is an intuitive, high performance, easy to use solution to complement our existing Criticool hypothermia systems from Belmont Medical Technologies. This will provide critical brain health information for infants suffering from hypoxic-ischemic encephalopathy (HIE) as well as the pre-term infant populations. We are excited to work closely with ANT Neuro and to introduce the nëo monitor to our NICU’s in Hong Kong and Macau, helping with these smallest and most fragile patients,” says Jules Flach, Founder and CEO of Pacific Medical Systems Limited.

Bernd Tebje, Director of International Sales at ANT Neuro adds: “The nëo™, which has just received the FDA 510k clearance, is the newest, most easy to use Cerebral Function Monitoring (CFM) solution available for the busy NICUs. Designed to account for NICU workflows, from electrode application, to monitoring, event annotation and review, it can easily integrate into neonatal brain monitoring protocols. We are very happy to formalise our distribution agreement for Hong Kong and Macau with Pacific Medical Systems, which is already having a well-established business in the field of Neonatal Intensive Care.”

More info: ANT Neuro